All News

A urine test that is under development appears to show significant specificity when used to detect prostate cancer, according to a multi-institution study from researchers in Colorado, Pennsylvania, New York, and Virginia presented at the AUA annual meeting in San Francisco.

A 17-year-long community study looking at symptoms of BPH in more than 2,000 men aged 40 to 79 years suggests that surgery offers more relief from incontinence and symptoms of obstruction than treatment from drug-based therapy.

Continuous androgen deprivation plus external beam radiation therapy should be the standard treatment approach for men with locally advanced prostate cancer, researchers reported at the American Society of Clinical Oncology annual meeting in Chicago.

With the IRA generally representing most physicians' largest financial asset, it only makes sense to ensure that retirement account beneficiary decisions are carefully made.

Most biochemical recurrence of prostate cancer following radical prostatectomy occurs within 10 years, and patients who remain free from progression a decade postoperatively can be counseled that their risk of subsequent cancer-related morbidity and mortality is low.

New products and services from Ethicon, MeridianEMR, the American Society for Radiation Oncology, and ALOKA Co., Ltd.

Perioperative urine cultures yield a high number of false-negative and false-positive results and do not accurately identify infective organisms in a large percentage of percutaneous nephrolithotomy patients.

Chronic prostatitis/chronic pelvic pain syndrome is a complex, heterogeneous syndrome in terms of etiology and symptoms, making its treatment difficult. Thus, a first step to improved management of these conditions is to better classify and stratify patients.

Percutaneous nephrolithotomy is considered the gold standard for the removal of large renal stones. Until recently, however, the procedure's efficacy had not been verified by a clinical study as large as a gold-standard procedure would seem to require.

A new study indicates that existing evidence is insufficient to show that most of the tort reforms sought-with the exception of caps on noneconomic damages-would be effective in reducing malpractice claims frequency and costs and defensive medicine, or improving the supply of health care services and quality of care.

Conflicting data on fascial defect size and port fixity render any perception of surgical advantage per port type as theoretical. Thus, regarding this aspect, the decision to use bladed or non-bladed trocars is likely best left to surgeon preference.